Correlation Between Formosa Laboratories and Sinphar Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Formosa Laboratories and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Formosa Laboratories and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Formosa Laboratories and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Formosa Laboratories and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Formosa Laboratories with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Formosa Laboratories and Sinphar Pharmaceutical.

Diversification Opportunities for Formosa Laboratories and Sinphar Pharmaceutical

0.61

Correlation Coefficient

Formosa Laboratories  Sinphar Pharmaceutical

Poor diversification

The 3 months correlation between Formosa and Sinphar is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Formosa Laboratories and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Formosa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Formosa Laboratories are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Formosa Laboratories i.e., Formosa Laboratories and Sinphar Pharmaceutical go up and down completely randomly.

Pair Corralation between Formosa Laboratories and Sinphar Pharmaceutical

Assuming the 90 days trading horizon Formosa Laboratories is expected to under-perform the Sinphar Pharmaceutical. In addition to that, Formosa Laboratories is 2.99 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.16 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.18 per unit of volatility. If you would invest  3,230  in Sinphar Pharmaceutical Co on September 13, 2024 and sell it today you would lose (225.00) from holding Sinphar Pharmaceutical Co or give up 6.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Formosa Laboratories  vs.  Sinphar Pharmaceutical Co

Formosa Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Formosa Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Formosa Laboratories and Sinphar Pharmaceutical

The main advantage of trading using opposite Formosa Laboratories and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Formosa Laboratories position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.

The idea behind Formosa Laboratories and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.